These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases. Lloyd-Evans E; Platt FM Cell Calcium; 2011 Aug; 50(2):200-5. PubMed ID: 21724254 [TBL] [Abstract][Full Text] [Related]
65. Newborn screening of lysosomal storage disorders. Marsden D; Levy H Clin Chem; 2010 Jul; 56(7):1071-9. PubMed ID: 20489136 [TBL] [Abstract][Full Text] [Related]
66. Insights into the diagnosis and treatment of lysosomal storage diseases. Wenger DA; Coppola S; Liu SL Arch Neurol; 2003 Mar; 60(3):322-8. PubMed ID: 12633142 [TBL] [Abstract][Full Text] [Related]
70. Novel biomarkers for lysosomal storage disorders: Metabolomic and proteomic approaches. Elmonem MA; Abdelazim AM Clin Chim Acta; 2020 Oct; 509():195-209. PubMed ID: 32561345 [TBL] [Abstract][Full Text] [Related]
71. [Lysosomal storage diseases - update and new therapeutic options]. Schöpfer K; Miebach E; Beck M; Pitz S Klin Monbl Augenheilkd; 2011 Feb; 228(2):144-60. PubMed ID: 20309790 [TBL] [Abstract][Full Text] [Related]
72. Treatment strategies for lysosomal storage disorders. Beck M Dev Med Child Neurol; 2018 Jan; 60(1):13-18. PubMed ID: 29090451 [TBL] [Abstract][Full Text] [Related]
73. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Desnick RJ; Schuchman EH Annu Rev Genomics Hum Genet; 2012; 13():307-35. PubMed ID: 22970722 [TBL] [Abstract][Full Text] [Related]
74. [Lysosomal Storage Diseases: Challenges in Multiprofessional Patient Care with Enzyme Replacement Therapy]. Das AM; Lagler F; Beck M; Scarpa M; Lampe C Klin Padiatr; 2017 May; 229(3):168-174. PubMed ID: 28464188 [No Abstract] [Full Text] [Related]
75. Neural stem cell-mediated therapy for rare brain diseases: perspectives in the near future for LSDs and MNDs. de Filippis L Histol Histopathol; 2011 Aug; 26(8):1093-109. PubMed ID: 21692041 [TBL] [Abstract][Full Text] [Related]
76. Gaucher disease and other storage disorders. Grabowski GA Hematology Am Soc Hematol Educ Program; 2012; 2012():13-8. PubMed ID: 23233555 [TBL] [Abstract][Full Text] [Related]
77. Novel treatment for neuronopathic lysosomal storage diseases--cell therapy/gene therapy. Eto Y; Ohashi T Curr Mol Med; 2002 Feb; 2(1):83-9. PubMed ID: 11898850 [TBL] [Abstract][Full Text] [Related]
78. Treating lysosomal storage disorders: current practice and future prospects. Platt FM; Lachmann RH Biochim Biophys Acta; 2009 Apr; 1793(4):737-45. PubMed ID: 18824038 [TBL] [Abstract][Full Text] [Related]
79. Gene therapy for lysosomal storage disorders. Yew NS; Cheng SH Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():99-109. PubMed ID: 24380128 [TBL] [Abstract][Full Text] [Related]
80. Stem cell therapies for the lysosomal storage diseases - the quintessential neurodegenerative diseases. Schwartz PH; Brick DJ Curr Stem Cell Res Ther; 2008 May; 3(2):88-98. PubMed ID: 18473875 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]